pyrazines has been researched along with icg 001 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, J; Hao, J; Li, Z; Lian, X; Qin, T; Wu, H; Wu, J; Wu, S; Zhang, W; Zhou, Q | 1 |
| Albany, C; Chovanec, M; Cierna, Z; Kalavska, K; Konig, H; Kucerova, L; Liskova, V; Matuskova, M; Mego, M; Miklikova, S; Plava, J; Rogozea, A; Rojikova, L; Schmidtova, S | 1 |
2 other study(ies) available for pyrazines and icg 001
| Article | Year |
|---|---|
Discovery and structure-activity relationship study of phthalimide-phenylpyridine conjugate as inhibitor of Wnt pathway.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Molecular Structure; Pyrazines; Pyridines; Pyrimidinones; Signal Transduction; Structure-Activity Relationship; Wnt Signaling Pathway | 2019 |
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Male; Mice; Mice, SCID; Neoplasms, Germ Cell and Embryonal; Pyrazines; Pyridines; Pyrimidinones; Testicular Neoplasms; Wnt Signaling Pathway | 2021 |